Responses were rapid and durable, and tumour shrinkage was observed in 82 percent of patients1 New findings from this investigational…
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…
The board of directors of Virbac specifies Paul Martingell's compensation terms as chief executive officer. The board of directors, acting…
Tuesday 15 April, 2025 Date: June 13 - June 21, 2025 Location: Germany, Austria, Italy, and Monaco Duration: 8 days…
MIAMI, June 4, 2025 /PRNewswire/ -- Enfinity Global Inc., a leading renewable energy company, has sold c. 49% minority interest…